Patents Assigned to Board of Trustees of the Leland Stanford Junior University
  • Patent number: 12236599
    Abstract: A system and method for analyzing a plurality of tissue image samples at different stages of image processing in order to establish the level of fibrosis within a patient from which the tissue image sample was retrieved. Various embodiments incorporate machine learning techniques which enable an automated progressive approach to effectively and efficiently diagnosing fibrotic conditions based on tissue image samples.
    Type: Grant
    Filed: July 27, 2020
    Date of Patent: February 25, 2025
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Shamik Mascharak, Heather E. Talbott, Mimi Borrelli, Alessandra Laura Moore, Michael T. Longaker
  • Patent number: 12237432
    Abstract: A vertically selective liftoff scribing process is provided. One application is the fabrication of solar cells and solar modules. The basis of this technology is absorption of an indirectly focused laser beam in the front electrode material of the device, which enables removal of this layer (e.g., a P1 scribe) or removal of layers above the front electrode while leaving the front electrode intact (e.g., a P2 or P3 scribe). The laser fluence can be selected to choose between these alternatives, and further fine tuning is possible depending on details of the device structure.
    Type: Grant
    Filed: September 11, 2023
    Date of Patent: February 25, 2025
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Austin Flick, Reinhold H. Dauskardt
  • Patent number: 12233462
    Abstract: A consolidated metallic glass structure is formed by fabricating [200] metallic glass nanoparticles with a solution-phase synthesis that provides coated metallic glass nanoparticles with a polymer ligand layer; stripping [202] the polymer ligand layer from the coated metallic glass nanoparticles to provide bare metallic glass nanoparticles; depositing [204] the bare metallic glass nanoparticles on a substrate to provide a deposited structure; and sintering [206] the deposited structure with heat and/or pressure to provide the consolidated metallic glass structure. The metallic glass nanoparticles are preferably composed substantially of nickel and boron, iron and boron, or cobalt and boron.
    Type: Grant
    Filed: October 10, 2020
    Date of Patent: February 25, 2025
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Xun Gu, Mehrdad T Kiani
  • Patent number: 12233093
    Abstract: The present invention provides a clinically applicable method of stem cell transplantation that facilitates engraftment and reconstitutes immunocompetence of the recipient without requiring radiotherapy or chemotherapy, and without development of GVHD or graft rejection. Aspects of the present invention are based on the discovery that the depletion of the endogenous stem cell niche facilitates efficient engraftment of stem cells into that niche. In particular, the present invention combines the use of selective ablation of endogenous stem cells with a combination of antibodies specific for CD117, and agents that modulate immunoregulatory signaling pathways, e.g. agonists of immune costimulatory molecules, in combination with the administration to the recipient of exogenous stem cells, resulting in efficient, long-term engraftment, even in immunocompetent recipients.
    Type: Grant
    Filed: July 18, 2022
    Date of Patent: February 25, 2025
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Judith A. Shizuru, Irving L. Weissman, Kipp Andrew Weiskopf, Aaron Michael Ring, Akanksha Chhabra, Peter Schnorr
  • Patent number: 12226892
    Abstract: A versatile, compact, and high-fidelity haptic device is provided. The mechanical transparency of the design and the selection of proper actuation meet the challenges of an accurate and stiff haptic device with high and isotropic force capability. Such a haptic interface enables a precise remote control and provides perfect sense of the task interaction in any environments and applications.
    Type: Grant
    Filed: September 7, 2021
    Date of Patent: February 18, 2025
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Margot R. Vulliez, Oussama Khatib
  • Patent number: 12226913
    Abstract: Methods and systems to remotely operate robotic devices are provided. A number of embodiments allow users to remotely operate robotic devices using generalized consumer devices (e.g., cell phones). Additional embodiments provide for a platform to allow communication between consumer devices and the robotic devices. Further embodiments allow for training robotic devices to operate autonomously by training the robotic device with machine learning algorithms using data collected from scalable methods of controlling robotic devices.
    Type: Grant
    Filed: November 2, 2020
    Date of Patent: February 18, 2025
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Ajay U. Mandlekar, Yuke Zhu, Animesh Garg, Silvio Savarese, Fei-Fei Li
  • Patent number: 12227741
    Abstract: The invention provides methods of performing multi-parameter analysis of single cells. Specifically, the present invention is based, in part, on leveraging a separation of reaction volume scales to conduct high-throughput single cell multi-parameter measurements and library preparation on the same single cell using double emulsion micro-droplets and sorting using flow cytometry.
    Type: Grant
    Filed: July 1, 2019
    Date of Patent: February 18, 2025
    Assignees: CZ Biohub SF, LLC, The Board of Trustees of the Leland Stanford Junior University
    Inventors: Polly Fordyce, Kara Brower, Sandy Klemm, William Greenleaf
  • Patent number: 12222413
    Abstract: In a method for magnetic resonance imaging pseudorandomly undersampled k-space imaging data is acquired with multiple receiver coils of an MRI imaging apparatus. MR image reconstruction is performed to produce a reconstructed MR image from the k-space imaging data by iteratively solving sketched approximations of an original reconstruction problem. The sketched approximations use a sketched model matrix As that is a lower-dimensional version of an original model matrix A of the original reconstruction problem. The sketched model matrix As preserves the Fourier structure of the MR reconstruction problem and reduces the number of coils actively used during reconstruction.
    Type: Grant
    Filed: May 13, 2022
    Date of Patent: February 11, 2025
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Julio A. Oscanoa Aida, Frank Ong, Mert Pilanci, Shreyas S. Vasanawala
  • Patent number: 12220444
    Abstract: Treatment of hyperinsulinemic hypoglycemia comprises administration of an effective amount of a glucagon-like peptide-1 receptor antagonist (GLP1RA) alone or in combination with an amylinomimetic agent or any anti-gastric emptying agent. Patients suffering from hyperinsulinemic hypoglycemia after bariatric surgery experience particular benefit, as there is no current method effective for their treatment. Prevention or reduction of acute adverse effects of postprandial hypoglycemia, such as palpitations, tremor, weakness, sweating, confusion, fatigue, blurred vision, seizures, or loss of consciousness, and prevention of chronic adverse effects of hyperinsulinemic hypoglycemia, such as cognitive impairment, can be achieved by treatment with GLP1RA.
    Type: Grant
    Filed: February 22, 2023
    Date of Patent: February 11, 2025
    Assignee: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
    Inventors: Tracey L. McLaughlin, Colleen M. Craig
  • Patent number: 12221469
    Abstract: The present disclosure generally relates to, inter alia, a class of chimeric switch receptors containing an endodomain of an IL-9 receptor, engineered to modulate transcriptional regulation in a ligand-dependent manner. The disclosure also provides compositions and methods useful for producing such receptors, nucleic acids encoding same, host cells genetically modified with the nucleic acids, as well as methods for modulating gene expression, modulating an activity of a cell, and/or for the treatment of various health conditions or diseases.
    Type: Grant
    Filed: June 2, 2023
    Date of Patent: February 11, 2025
    Assignees: PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY, THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
    Inventors: John Connolly, Sean Parker, Kenan Christopher Garcia
  • Patent number: 12214199
    Abstract: The present invention provides, inter alia, methods, apparatus, and systems useful for ameliorating impulse control disorders known to be extremely disabling and common to many neurological and psychiatric conditions using closed-loop (responsive) neuro stimulation.
    Type: Grant
    Filed: March 22, 2023
    Date of Patent: February 4, 2025
    Assignee: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
    Inventors: Casey Halpern, Robert C. Malenka, Hemmings Wu
  • Patent number: 12217519
    Abstract: A method for 3D object detection is described. The method includes predicting, using a trained monocular depth network, an estimated monocular input depth map of a monocular image of a video stream and an estimated depth uncertainty map associated with the estimated monocular input depth map. The method also includes feeding back a depth uncertainty regression loss associated with the estimated monocular input depth map during training of the trained monocular depth network to update the estimated monocular input depth map. The method further includes detecting 3D objects from a 3D point cloud computed from the estimated monocular input depth map based on seed positions selected from the 3D point cloud and the estimated depth uncertainty map. The method also includes selecting 3D bounding boxes of the 3D objects detected from the 3D point cloud based on the seed positions and an aggregated depth uncertainty.
    Type: Grant
    Filed: December 6, 2021
    Date of Patent: February 4, 2025
    Assignees: TOYOTA RESEARCH INSTITUTE, INC., THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
    Inventors: Rares Andrei Ambrus, Or Litany, Vitor Guizilini, Leonidas Guibas, Adrien David Gaidon, Jie Li
  • Patent number: 12213894
    Abstract: A portable device, method and system are provided for automated, quantitative assessment of orbital compliance and soft tissue restriction with emphasis on applicability to orbital trauma and fracture management is provided.
    Type: Grant
    Filed: June 4, 2020
    Date of Patent: February 4, 2025
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Benjamin Peter Erickson, Henry Bair
  • Patent number: 12215341
    Abstract: There are provided herein, inter alia, complexes, compositions and methods for the delivery of nucleic acid into a cell in vivo. The complexes, compositions and methods may facilitate complexation, protection, delivery and release of oligonucleotides and polyanionic cargos into target cells, tissues, and organs both in vitro and in vivo.
    Type: Grant
    Filed: November 11, 2019
    Date of Patent: February 4, 2025
    Assignee: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
    Inventors: Tim R. Blake, Robert M. Waymouth, Paul Wender, Ronald Levy, Ole Audun Werner Haabeth, Matthew Frank, Adrienne Sallets
  • Patent number: 12213825
    Abstract: A method of x-ray fluoroscopy images a region of interest at distinct first and second imaging projection angles using digital subtraction x-ray fluoroscopic imaging with a fiducial marker board positioned in a field of view containing the region of interest to produce first and second sets of images. Image segmentation information is determined to identify an anatomical feature in the region of interest imaged in the first set of images and the second set of images. The region of interest is then imaged using x-ray fluoroscopic imaging, again with the fiducial marker board positioned in a third field of view containing the region of interest, but without digital subtraction, to produce a third set of images. A virtual image of the anatomical feature is projected onto the third set of images, computed from the image segmentation information and from a predetermined geometric relationship of markers within the fiducial marker board.
    Type: Grant
    Filed: April 29, 2022
    Date of Patent: February 4, 2025
    Assignees: The Board of Trustees of the Leland Stanford Junior University, Pulmera, Inc.
    Inventors: Bryan I. Hartley, Harmeet Bedi, Rene Vargas-Voracek, Norbert J. Pelc
  • Publication number: 20250037788
    Abstract: Methods and systems for constructing gene modules with regulator genes and target genes are provided. A Gaussian mixed model can construct gene modules using RNA sequencing data. Sets of gene modules can be compared to identify shared or unique biological processes.
    Type: Application
    Filed: November 22, 2022
    Publication date: January 30, 2025
    Applicant: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Shaimaa Hesham Bakr, Olivier Gevaert
  • Publication number: 20250032459
    Abstract: The present invention is directed to a method for treating a neurodegenerative disease such as amyotrophic lateral sclerosis (ALS), Alzheimer disease, Parkinson's disease, Huntington's disease, frontotemporal degeneration, dementia with Lewy bodies, a motor neuron disease, or a demyelinating disease. The method comprises administering to a subject in need thereof a Ppargc1a activator 2-(4-tert-butylphenyl)-1H-benzimidazole, 2-[4-(1,1-dimethylethyl)phenyl]-1H-benzimidazole, in an effective amount. A preferred route of administration is oral administration.
    Type: Application
    Filed: October 9, 2024
    Publication date: January 30, 2025
    Applicant: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
    Inventors: Khoa Dinh NGUYEN, Edgar G. ENGLEMAN
  • Publication number: 20250036919
    Abstract: A brain machine interface (BMI) to control a device is provided. The BMI has a neural decoder, which is a neural to kinematic mapping function with neural signals as input to the neural decoder and kinematics to control the device as output of the neural decoder. The neural decoder is based on a continuous-time multiplicative recurrent neural network, which has been trained as a neural to kinematic mapping function. An advantage of the invention is the robustness of the decoder to perturbations in the neural data; its performance degrades less—or not at all in some circumstances—in comparison to the current state decoders. These perturbations make the current use of BMI in a clinical setting extremely challenging. This invention helps to ameliorate this problem. The robustness of the neural decoder does not come at the cost of some performance, in fact an improvement in performance is observed.
    Type: Application
    Filed: April 19, 2024
    Publication date: January 30, 2025
    Applicant: The Board of Trustees of the Leland Stanford Junior University
    Inventors: David Sussillo, Jonathan C. Kao, Sergey Stavisky, Krishna V. Shenoy
  • Patent number: 12212292
    Abstract: In certain examples, the disclosure involves or is directed to a circuit-based apparatus that has a T-network, and a plurality of circuit paths with a first path having a first switching node to respond to an RF input signal that is characterized by a first phase, and with a second path having a second switching node to respond to the RF input signal characterized by a second phase that is different than the first phase. The circuit paths may be configured as a push-pull amplification circuit. The T-network may be arranged between the first and second switching nodes and may include a variable impedance circuit. The variable impedance circuit may be adjusted, in accordance with a selected frequency of the RF input signal. The T-network may be characterized by a resonance frequency shunts a second harmonic current associated with the resonance frequency, thereby permitting for use of different selected frequencies.
    Type: Grant
    Filed: September 28, 2021
    Date of Patent: January 28, 2025
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Zikang Tong, Lei Gu, Juan Rivas-Davila
  • Patent number: 12201410
    Abstract: Systems and methods for clinical neuronavigation in accordance with embodiments of the invention are illustrated. One embodiment includes a method for generating a brain stimulation target, including obtaining functional magnetic resonance imaging (fMRI) image data of a patient's brain, where brain imaging data describes neuronal activations within the patient's brain, determining a brain stimulation target by mapping at least one region of interest to the patient's brain, locating functional subregions within the at least one region of interest based on the fMRI image data, determining functional relationships between at least two brain regions of interest, generating parameters for each functional subregion, generating a target quality score for each functional subregion based on the parameters and selecting a brain stimulation target based on its target quality score and the patient's neurological condition.
    Type: Grant
    Filed: January 3, 2022
    Date of Patent: January 21, 2025
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Nolan Williams, Keith Sudheimer